Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroscience-Based Aphasia Therapy Adapted to Remote, Mobile-Based Treatment

NCT05274360 is registered in ClinicalTrials.gov with Institute for Bioengineering of Catalonia as lead sponsor.

NCT NCT05274360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05274360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroscience-Based Aphasia Therapy Adapted to Remote, Mobile-Based Treatment
Lead sponsor
Institute for Bioengineering of Catalonia
Phase
Not applicable
Overall status
Completed
Start date
November 29, 2021
Completion date
December 29, 2021
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia, aphasia, broca, aphasia, fluent, aphasia, nonfluent, aphasia, wernicke